Myocarditis and Chronic Inflammatory Cardiomyopathy, from Acute Inflammation to Chronic Inflammatory Damage: An Update on Pathophysiology and Diagnosis
Open accessThe DOI matches its Crossref record; 132 of the 133 references it cites were found in a registry or an index.
Abstract
Acute myocarditis covers a wide spectrum of clinical presentations, from uncomplicated myocarditis to severe forms complicated by hemodynamic instability and ventricular arrhythmias; however, all these forms are characterized by acute myocardial inflammation. The term “chronic inflammatory cardiomyopathy” describes a persistent/chronic inflammatory condition with a clinical phenotype of dilated and/or hypokinetic cardiomyopathy associated with symptoms of heart failure and increased risk for arrhythmias. A continuum can be identified between these two conditions. The importance of early diagnosis has grown markedly in the contemporary era with various diagnostic tools available. While cardiac magnetic resonance (CMR) is valid for diagnosis and follow-up, endomyocardial biopsy (EMB) should be considered as a first-line diagnostic modality in all unexplained acute cardiomyopathies complicated by hemodynamic instability and ventricular arrhythmias, considering the local expertise. Genetic counseling should be recommended in those cases where a genotype–phenotype association is suspected, as this has significant implications for patients’ and their family members’ prognoses. Recognition of the pathophysiological pathway and clinical “red flags” and an early diagnosis may help us understand mechanisms of progression, tailor long-term preventive and therapeutic strategies for this complex disease, and ultimately improve clinical outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, during EAM, dysregulated macrophage–cardiomyocyte interactions impair contractility and exacerbate tissue damage [3,8,10].”
From Cardiac Macrophages Exhibit Dynamic Heterogeneity and Functional Specialization During Experimental Autoimmune Myocarditis. (2026) · cites this paper as [3]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Currently, standard non-specific immunosuppressive therapies risk silencing reparative macrophage populations, highlighting the critical need to map specific functional subsets and their spatial niches for precision immunomodulation [3,10,16].”
From Cardiac Macrophages Exhibit Dynamic Heterogeneity and Functional Specialization During Experimental Autoimmune Myocarditis. (2026) · cites this paper as [3]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Endothelial cell infection and endotheliitis in COVID-19
Varga, Z., Flammer, A. J., Steiger, P., Haberecker, M., Andermatt, R., Zinkernagel, A. S., Mehra, M. R., Schuepbach, R. A., Ruschitzka, F., & Moch, H. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30937-5 · Cited by 6,358 · cited 1×
“GCM is a rare disorder presenting often with a fulminant course requiring a prompt histological diagnosis and immediate immunosuppressive treatment [16].”
BackgroundCaforio, A. L. P., Pankuweit, S., Arbustini, E., Basso, C., Gimeno-Blanes, J., Felix, S. B., Fu, M., Heliö, T., Heymans, S., Jahns, R., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht210 · Cited by 3,479 · cited 3×
“Subsequent studies have clarified the efficacy of immunosuppression in terms of cardiac function but not in terms of survival benefit [127] and therapy often remains eminence-rather than evidence-based.”
Background2023 ESC guidelines for the management of cardiomyopathies
Arbelo, E., Protonotarios, A., Gimeno, J. R., Arbustini, E., Barriales-Villa, R., Basso, C., Bezzina, C. R., Biagini, E., Blom, N. A., de Boer, R. A., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad194 · Cited by 2,844 · cited 1×
“To date, it remains to be clarified whether an inflammatory trigger is the “primum movens” that determines cardiomyocytes’ damage, necrosis, and the consequent repair process with fibrofatty infiltration or if inflammation is rather a reactive phenomenon following myocyte loss [98].”
BackgroundCardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper
Friedrich, M. G., Sechtem, U., Schulz-Menger, J., Holmvang, G., Alakija, P., Cooper, L. T., White, J. A., Abdel-Aty, H., Gutberlet, M., Prasad, S., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.02.007 · Cited by 2,509
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
Johnson, D. B., Balko, J. M., Compton, M. L., Chalkias, S., Gorham, J., Xu, Y., Hicks, M., Puzanov, I., Alexander, M. R., Bloomer, T. L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1609214 · Cited by 2,308 · cited 1×
“More frequently, it occurs in the presence of systemic autoimmune diseases such as Eosinophilic granulomatosis with polyangiitis (EGPA), hypersensitivity reaction to drugs, in the rare hypereosinophilic syndrome with the myeloproliferative or idiopathic form, or in the case of parasitic infections.”
BackgroundAuthors/Task Force Members:, McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., et al. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2333 · Cited by 2,171
Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation
Ferreira, V. M., Schulz-Menger, J., Holmvang, G., Kramer, C. M., Carbone, I., Sechtem, U., Kindermann, I., Gutberlet, M., Cooper, L. T., Liu, P., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.09.072 · Cited by 2,059
Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
Mahmood, S. S., Fradley, M. G., Cohen, J. V., Nohria, A., Reynolds, K. L., Heinzerling, L. M., Sullivan, R. J., Damrongwatanasuk, R., Chen, C. L., Gupta, D., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.02.037 · Cited by 1,608
Birnie, D. H., Sauer, W. H., Bogun, F., Cooper, J. M., Culver, D. A., Duvernoy, C. S., Judson, M. A., Kron, J., Mehta, D., Cosedis Nielsen, J., et al. (2014) · Heart Rhythm · doi:10.1016/j.hrthm.2014.03.043 · Cited by 1,479 · cited 1×
“The use of corticosteroids is often the fi rst line of treat-ment, frequently in combination with intravenous immunoglobulin, cyclophosphamide, or rituximab during the acute phase, while for maintenance therapy, mycophenolate mofetil”
BackgroundA Clinical Trial of Immunosuppressive Therapy for Myocarditis
Mason, J. W., O'Connell, J. B., Herskowitz, A., Rose, N. R., McManus, B. M., Billingham, M. E., & Moon, T. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508033330501 · Cited by 1,274 · cited 1×
“Close collaboration between cardiologists and other specialists should be promoted to identify cardiac involvement promptly and define therapeutic strategies and prognostication.”
BackgroundMyocarditis and inflammatory cardiomyopathy: current evidence and future directions
Tschöpe, C., Ammirati, E., Bozkurt, B., Caforio, A. L. P., Cooper, L. T., Felix, S. B., Hare, J. M., Heidecker, B., Heymans, S., Hübner, N., et al. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-020-00435-x · Cited by 1,217 · cited 3×
“AM is de fi ned as an acute in fl ammation of the myocardium caused by a direct path-ogen insult and/or exaggerated immune response [1].”
BackgroundInfluentialArrhythmogenic Right Ventricular Cardiomyopathy: Dysplasia, Dystrophy, or Myocarditis?
Basso, C., Thiene, G., Corrado, D., Angelini, A., Nava, A., & Valente, M. (1996) · Circulation · doi:10.1161/01.cir.94.5.983 · Cited by 890
Ammirati, E., Frigerio, M., Adler, E. D., Basso, C., Birnie, D. H., Brambatti, M., Friedrich, M. G., Klingel, K., Lehtonen, J., Moslehi, J. J., et al. (2020) · Circulation: Heart Failure · doi:10.1161/circheartfailure.120.007405 · Cited by 811 · cited 2×
“Some studies suggest that a mis-activation of M2 macrophages, regulatory cells implicated in immunosuppressive functions, causes a late inflammatory response and progression towards chronic cardiac fibrosis.”
BackgroundThe heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy
Bulkley, B. H., & Roberts, W. C. (1975) · The American Journal of Medicine · doi:10.1016/0002-9343(75)90575-6 · Cited by 670 · cited 2×
“Furthermore, due to vasculitis-related coronary artery disease, it is not uncommon to detect regional wall motion abnormalities or aneurismal wall thinning.”
BackgroundMethodViral myocarditis—diagnosis, treatment options, and current controversies
Pollack, A., Kontorovich, A. R., Fuster, V., & Dec, G. W. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.108 · Cited by 657
Kociol, R. D., Cooper, L. T., Fang, J. C., Moslehi, J. J., Pang, P. S., Sabe, M. A., Shah, R. V., Sims, D. B., Thiene, G., Vardeny, O., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000745 · Cited by 625 · cited 1×
“…than supportive measures, although the use of anti-viral drugs should be considered in herpes virus infection [123]. viral acute myocarditis, there are no targeted therapies [6] other than supportive measures although the use of anti-viral drugs should be considered in herpes virus infection [123].”
BackgroundFrustaci, A., Russo, M. A., & Chimenti, C. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp249 · Cited by 604
Cardiac Sarcoidosis: Epidemiology, Characteristics, and Outcome Over 25 Years in a Nationwide Study
Kandolin, R., Lehtonen, J., Airaksinen, J., Vihinen, T., Miettinen, H., Ylitalo, K., Kaikkonen, K., Tuohinen, S., Haataja, P., Kerola, T., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.011522 · Cited by 582
Controlled Trial of Intravenous Immune Globulin in Recent-Onset Dilated Cardiomyopathy
McNamara, D. M., Holubkov, R., Starling, R. C., Dec, G. W., Loh, E., Torre-Amione, G., Gass, A., Janosko, K., Tokarczyk, T., Kessler, P., et al. (2001) · Circulation · doi:10.1161/01.cir.103.18.2254 · Cited by 560 · cited 1×
“The efficacy of immunosuppression has been demonstrated only in specific diseases, with controversial benefits on survival.”
BackgroundRobson, J. C., Grayson, P. C., Ponte, C., Suppiah, R., Craven, A., Judge, A., Khalid, S., Hutchings, A., Watts, R. A., Merkel, P. A., et al. (2022) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2021-221795 · Cited by 492
Sarcoidosis: A Clinical Overview from Symptoms to Diagnosis
Sève, P., Pacheco, Y., Durupt, F., Jamilloux, Y., Gerfaud-Valentin, M., Isaac, S., Boussel, L., Calender, A., Androdias, G., Valeyre, D., et al. (2021) · Cells · doi:10.3390/cells10040766 · Cited by 487
JCS 2016 Guideline on Diagnosis and Treatment of Cardiac Sarcoidosis ― Digest Version ―
Terasaki, F., Azuma, A., Anzai, T., Ishizaka, N., Ishida, Y., Isobe, M., Inomata, T., Ishibashi-Ueda, H., Eishi, Y., Kitakaze, M., et al. (2019) · Circulation Journal · doi:10.1253/circj.cj-19-0508 · Cited by 479 · cited 1×
“The use of corticosteroids is often the fi rst line of treat-ment, frequently in combination with intravenous immunoglobulin, cyclophosphamide, or rituximab during the acute phase, while for maintenance therapy, mycophenolate mofetil”
Backgroundvan der Zwaag, P. A., van Rijsingen, I. A. W., Asimaki, A., Jongbloed, J. D. H., van Veldhuisen, D. J., Wiesfeld, A. C. P., Cox, M. G. P. J., van Lochem, L. T., de Boer, R. A., Hofstra, R. M. W., et al. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs119 · Cited by 465 · cited 1×
“A positive FDG-PET in a patient with persistent troponin elevation should trigger further diagnostic steps, such as an EMB, especially in the presence of arrhythmias [113].”
BackgroundWojnicz, R., Nowalany-Kozielska, E., Wojciechowska, C., Glanowska, G., Wilczewski, P., Niklewski, T., Zembala, M., Poloński, L., Rozek, M. M., & Wodniecki, J. (2001) · Circulation · doi:10.1161/01.cir.104.1.39 · Cited by 459 · cited 1×
“Close collaboration between cardiologists and other specialists should be promoted to identify cardiac involvement promptly and define therapeutic strategies and prognostication.”
BackgroundCardiovascular manifestations of systemic lupus erythematosus
Doherty, N. E., & Siegel, R. J. (1985) · American Heart Journal · doi:10.1016/0002-8703(85)90023-7 · Cited by 418 · cited 4×
“The frequency of SLE-related myocarditis varies between different ethnicities, being higher in patients of African and Asian descent [73].”
BackgroundInfluentialDiagnosis and Treatment of Acute Myocarditis: A Review
Ammirati, E., & Moslehi, J. J. (2023) · JAMA · doi:10.1001/jama.2023.3371 · Cited by 379 · cited 2×
“It represents the most typical case of myocardial inflammatory disease, with an incidence of 4–14 per 100,000 individuals globally and a mortality rate between 1% and 7% [ Signs and symptoms usually include chest pain, dyspnoea, and palpitations, accompanied by elevation in high-sensitivity 5].”
BackgroundUsefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis.
Okumura, W., Iwasaki, T., Toyama, T., Iso, T., Arai, M., Oriuchi, N., Endo, K., Yokoyama, T., Suzuki, T., & Kurabayashi, M. (2004) · PubMed · Cited by 357
Brambatti, M., Matassini, M. V., Adler, E. D., Klingel, K., Camici, P. G., & Ammirati, E. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.09.023 · Cited by 337 · cited 2×
“Progressive LV end-diastolic volume with reduced ejection fraction is associated with signs of diastolic dysfunction and elevated E/e’ ratio; also, a decreased global longitudinal strain in preserved radial LV function can be an indicator of persistent myocardial inflammation [33].”
BackgroundBaldeviano, G. C., Barin, J. G., Talor, M. V., Srinivasan, S., Bedja, D., Zheng, D., Gabrielson, K., Iwakura, Y., Rose, N. R., & Cihakova, D. (2010) · Circulation Research · doi:10.1161/circresaha.109.213157 · Cited by 334 · cited 1×
“Markers of cardiac damage, such as troponin and natriuretic peptides, might be only mildly elevated in the chronic quiescent setting or be significantly raised in acute decompensated phases [31].”
BackgroundUsefulness of Immunosuppression for Giant Cell Myocarditis
Cooper, L. T., Hare, J. M., Tazelaar, H. D., Edwards, W. D., Starling, R. C., Deng, M. C., Menon, S., Mullen, G. M., Jaski, B., Bailey, K. R., et al. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.07.041 · Cited by 320 · cited 1×
“Close collaboration between cardiologists and other specialists should be promoted to identify cardiac involvement promptly and define therapeutic strategies and prognostication.”
BackgroundCardiac Involvement in Systemic Lupus Erythematosus
Moder, K. G., Miller, T. D., & Tazelaar, H. D. (1999) · Mayo Clinic Proceedings · doi:10.4065/74.3.275 · Cited by 297 · cited 1×
“Only 20% of patients with active SLE fulfilled clinical criteria for diagnosis of active myocarditis, while CMR was positive for myocarditis in 80% of patients [58].”
BackgroundUsefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis
奥村, 渉. (2005) · Medical Entomology and Zoology · Cited by 292
Inflammatory Cardiomyopathic Syndromes
Trachtenberg, B. H., & Hare, J. M. (2017) · Circulation Research · doi:10.1161/circresaha.117.310221 · Cited by 289 · cited 1×
“The transition from the acute phase to dilated cardiomyopathy (DCM) is not well defined.”
BackgroundD'Ambrosio, A. (2001) · Heart · doi:10.1136/heart.85.5.499 · Cited by 288
Hachulla, A.-L., Launay, D., Gaxotte, V, de Groote, P., Lamblin, N., Devos, P., Hatron, P.-Y., Beregi, J.-P., & Hachulla, E. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.095836 · Cited by 280
Caforio, A. L. P., Mahon, N. J., Tona, F., & McKenna, W. J. (2002) · European Journal of Heart Failure · doi:10.1016/s1388-9842(02)00010-7 · Cited by 273 · cited 1×
“CMR is the most accurate non-invasive technique to assess myocardial fibrosis and chronic inflammation.”
MethodAllanore, Y., Meune, C., Vonk, M. C., Airo, P., Hachulla, E., Caramaschi, P., Riemekasten, G., Cozzi, F., Beretta, L., Derk, C. T., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.103382 · Cited by 271
Caforio, A. L. P., Adler, Y., Agostini, C., Allanore, Y., Anastasakis, A., Arad, M., Böhm, M., Charron, P., Elliott, P. M., Eriksson, U., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx321 · Cited by 263 · cited 3×
“Typical findings are the presence of fibrosis detected with LGE in a patchy, non-ischemic (often mid-wall) distribution, even at the early stages of the disease in the absence of clinical cardiac manifestations [66].”
BackgroundCardiac Involvement in Churg-Strauss Syndrome: Impact of Endomyocarditis
Neumann, T., Manger, B., Schmid, M., Kroegel, C., Hansch, A., Kaiser, W. A., Reinhardt, D., Wolf, G., Hein, G., Mall, G., et al. (2009) · Medicine · doi:10.1097/md.0b013e3181af35a5 · Cited by 262
Cardiac sarcoidosis: state-of-the-art review
Kouranos, V., & Sharma, R. (2021) · Heart · doi:10.1136/heartjnl-2019-316442 · Cited by 259 · cited 3×
“Regardless of the primary myocardial involvement, as the disease progresses, patients develop HF symptoms and asymptomatic and symptomatic AVB.”
BackgroundPrognostic Value of Repeating Cardiac Magnetic Resonance in Patients With Acute Myocarditis
Aquaro, G. D., Ghebru Habtemicael, Y., Camastra, G., Monti, L., Dellegrottaglie, S., Moro, C., Lanzillo, C., Scatteia, A., Di Roma, M., Pontone, G., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.08.1061 · Cited by 253
Schelbert, E. B., Piehler, K. M., Zareba, K. M., Moon, J. C., Ugander, M., Messroghli, D. R., Valeti, U. S., Chang, C. H., Shroff, S. G., Diez, J., et al. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.002613 · Cited by 237
Kouranos, V., Tzelepis, G. E., Rapti, A., Mavrogeni, S., Aggeli, K., Douskou, M., Prasad, S., Koulouris, N., Sfikakis, P., Wells, A., et al. (2017) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2016.11.019 · Cited by 236 · cited 2×
“In 90% of cases presenting as multiform PVCs, the most frequent cardiac manifestations are arrhythmias, while sustained ventricular tachycardia and supraventricular arrhythmias are less frequent.”
BackgroundTavora, F., Cresswell, N., Li, L., Ripple, M., Solomon, C., & Burke, A. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.03.068 · Cited by 230
Impaired thymic tolerance to α-myosin directs autoimmunity to the heart in mice and humans
Lv, H., Havari, E., Pinto, S., Gottumukkala, R. V. S. R. K., Cornivelli, L., Raddassi, K., Matsui, T., Rosenzweig, A., Bronson, R. T., Smith, R., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44583 · Cited by 228
Heart involvement in systemic lupus erythematosus, anti-phospholipid syndrome and neonatal lupus
Tincani, A., Rebaioli, C. B., Taglietti, M., & Shoenfeld, Y. (2006) · Rheumatology · doi:10.1093/rheumatology/kel308 · Cited by 216 · cited 1×
“Furthermore, due to vasculitis-related coronary artery disease, it is not uncommon to detect regional wall motion abnormalities or aneurismal wall thinning.”
BackgroundChallenges in Cardiac and Pulmonary Sarcoidosis
Trivieri, M. G., Spagnolo, P., Birnie, D., Liu, P., Drake, W., Kovacic, J. C., Baughman, R., Fayad, Z. A., & Judson, M. A. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.08.042 · Cited by 216
Proposed diagnostic criteria for arrhythmogenic cardiomyopathy: European Task Force consensus report
Corrado, D., Anastasakis, A., Basso, C., Bauce, B., Blomström-Lundqvist, C., Bucciarelli-Ducci, C., Cipriani, A., De Asmundis, C., Gandjbakhch, E., Jiménez-Jáimez, J., et al. (2024) · International Journal of Cardiology · doi:10.1016/j.ijcard.2023.131447 · Cited by 190 · cited 1×
“An underlying inflammatory/immune mechanism to ARVC has been reported since 1996 when focal lymphocyte infiltrates and myocyte necrosis consistent with myocarditis were described in up to 67% of ARVC hearts on post-mortem examination [97].”
BackgroundGorbea, C., Makar, K. A., Pauschinger, M., Pratt, G., Bersola, J. L. F., Varela, J., David, R. M., Banks, L., Huang, C.-H., Li, H., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.047464 · Cited by 189 · cited 1×
“Electrocardiography shows a variety of nonspecific alterations—ST-T abnormalities, pathological Q-waves, poor R-wave progression in precordial leads, and fragmentation of QRS are common—supraventricular arrhythmias such as atrial fibrillation, sinus pauses, and conduction blocks, are possible.”
BackgroundDe novo desmin-mutation N116S is associated with arrhythmogenic right ventricular cardiomyopathy
Klauke, B., Kossmann, S., Gaertner, A., Brand, K., Stork, I., Brodehl, A., Dieding, M., Walhorn, V., Anselmetti, D., Gerdes, D., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq387 · Cited by 186 · cited 1×
“They had been initially postulated to contribute to the onset and progression of the disease; however, it seems more likely that viruses are benign bystanders rather than actual causative triggers.”
BackgroundFrantz, S., Falcao-Pires, I., Balligand, J.-L., Bauersachs, J., Brutsaert, D., Ciccarelli, M., Dawson, D., de Windt, L. J., Giacca, M., Hamdani, N., et al. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1138 · Cited by 184
Bennett, M. K., Gilotra, N. A., Harrington, C., Rao, S., Dunn, J. M., Freitag, T. B., Halushka, M. K., & Russell, S. D. (2013) · Circulation: Heart Failure · doi:10.1161/circheartfailure.112.000087 · Cited by 182 · cited 1×
“In these cases In these cases, treatment of complications, such as arrhythmias and HF, and the restriction of physical activity for 6 months are the most important measures [6].”
BackgroundWicks, E. C., Menezes, L. J., Barnes, A., Mohiddin, S. A., Sekhri, N., Porter, J. C., Booth, H. L., Garrett, E., Patel, R. S., Pavlou, M., et al. (2018) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jex340 · Cited by 174 · cited 1×
“Importantly, the presence of pulmonary hypertension, often secondary to lung involvement in SSc, must be carefully ruled out and followed up over time [58].”
BackgroundA genome-wide association study identifies 6p21 as novel risk locus for dilated cardiomyopathy
Meder, B., Rühle, F., Weis, T., Homuth, G., Keller, A., Franke, J., Peil, B., Lorenzo Bermejo, J., Frese, K., Huge, A., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/eht251 · Cited by 172 · cited 1×
“Furthermore, the use of LGE allows for the identification of necrosis or replacement fibrosis [34]; its persistence with the disappearance of edema is a marker of unfavorable prognosis, while the mid-wall septal LGE pattern is an independent predictor of cardiac events [35].”
Ekström, K., Lehtonen, J., Nordenswan, H.-K., Mäyränpää, M. I., Räisänen-Sokolowski, A., Kandolin, R., Simonen, P., Pietilä-Effati, P., Alatalo, A., Utriainen, S., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz428 · Cited by 169
Corticosteroids for Viral Myocarditis
Chen, H. S., Wang, W., Wu, S., & Liu, J. P. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004471.pub3 · Cited by 158 · cited 1×
“Close collaboration between cardiologists and other specialists should be promoted to identify cardiac involvement promptly and define therapeutic strategies and prognostication.”
Background‘Hot phase’ clinical presentation in arrhythmogenic cardiomyopathy
Bariani, R., Cipriani, A., Rizzo, S., Celeghin, R., Bueno Marinas, M., Giorgi, B., De Gaspari, M., Rigato, I., Leoni, L., Zorzi, A., et al. (2021) · EP Europace · doi:10.1093/europace/euaa343 · Cited by 154 · cited 3×
“A positive FDG-PET in a patient with persistent troponin elevation should trigger further diagnostic steps, such as an EMB, especially in the presence of arrhythmias [113].”
BackgroundAcute Myocarditis Associated With Desmosomal Gene Variants
Ammirati, E., Raimondi, F., Piriou, N., Sardo Infirri, L., Mohiddin, S. A., Mazzanti, A., Shenoy, C., Cavallari, U. A., Imazio, M., Aquaro, G. D., et al. (2022) · JACC: Heart Failure · doi:10.1016/j.jchf.2022.06.013 · Cited by 150 · cited 4×
“A positive FDG-PET in a patient with persistent troponin elevation should trigger further diagnostic steps, such as an EMB, especially in the presence of arrhythmias [113].”
BackgroundMethodInfluentialBlock, J. P., Boehmer, T. K., Forrest, C. B., Carton, T. W., Lee, G. M., Ajani, U. A., Christakis, D. A., Cowell, L. G., Draper, C., Ghildayal, N., et al. (2022) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7114e1 · Cited by 149 · cited 1×
“GCM is a rare disorder presenting often with a fulminant course requiring a prompt histological diagnosis and immediate immunosuppressive treatment [16].”
BackgroundNindl, V., Maier, R., Ratering, D., De Giuli, R., Züst, R., Thiel, V., Scandella, E., Di Padova, F., Kopf, M., Rudin, M., et al. (2012) · European Journal of Immunology · doi:10.1002/eji.201142209 · Cited by 141
Left Ventricular Diastolic Dysfunction Predicts Mortality in Patients With Systemic Sclerosis
Tennøe, A. H., Murbræch, K., Andreassen, J. C., Fretheim, H., Garen, T., Gude, E., Andreassen, A., Aakhus, S., Molberg, Ø., & Hoffmann‐Vold, A. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.07.068 · Cited by 141 · cited 1×
“In a recent study, T1 mapping showed an increase in extracellular volume in 50% of patients with SSc. One-third of these had had negative conventional cardiology screening tests [68].”
BackgroundGenetics of Myocarditis in Arrhythmogenic Right Ventricular Dysplasia
Lopez-Ayala, J. M., Pastor-Quirante, F., Gonzalez-Carrillo, J., Lopez-Cuenca, D., Sanchez-Munoz, J. J., Oliva-Sandoval, M. J., & Gimeno, J. R. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.01.001 · Cited by 140 · cited 1×
“A positive FDG-PET in a patient with persistent troponin elevation should trigger further diagnostic steps, such as an EMB, especially in the presence of arrhythmias [113].”
BackgroundJoyce, E., Ninaber, M. K., Katsanos, S., Debonnaire, P., Kamperidis, V., Bax, J. J., Taube, C., Delgado, V., & Ajmone Marsan, N. (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.205 · Cited by 133
Inflammation and Immune Response in Arrhythmogenic Cardiomyopathy: State-of-the-Art Review
Asatryan, B., Asimaki, A., Landstrom, A. P., Khanji, M. Y., Odening, K. E., Cooper, L. T., Marchlinski, F. E., Gelzer, A. R., Semsarian, C., Reichlin, T., et al. (2021) · Circulation · doi:10.1161/circulationaha.121.055890 · Cited by 132 · cited 1×
“…associated with Naxos disease; the mutation of other genes beyond desmosome has also been demonstrated to a lesser extent, like phospholamban (PLN), lamin A/C (LMNA), integrin-like kinase (ILK), titin (TTN) or genes encoding for area composita like cadherin-C (CDH-2) and alpha-T-catenin (CTNNA3).”
BackgroundMueller, K. A. L., Mueller, I. I., Eppler, D., Zuern, C. S., Seizer, P., Krämer, U., Koetter, I., Röcken, M., Kandolf, R., Gawaz, M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0126707 · Cited by 126 · cited 1×
“The use of corticosteroids is often the fi rst line of treat-ment, frequently in combination with intravenous immunoglobulin, cyclophosphamide, or rituximab during the acute phase, while for maintenance therapy, mycophenolate mofetil”
BackgroundApte, M., McGwin, G., Vila, L. M., Kaslow, R. A., Alarcon, G. S., Reveille, J. D., & for the LUMINA Study Group (2007) · Rheumatology · doi:10.1093/rheumatology/kem371 · Cited by 124 · cited 1×
“An accurate study on differences between the CMR findings in acute infective myocarditis and active SLE shows both a high T2 intensity signal and a high gadolinium enhancement intensity signal [84].”
BackgroundManagement of Patients With Giant Cell Myocarditis
Bang, V., Ganatra, S., Shah, S. P., Dani, S. S., Neilan, T. G., Thavendiranathan, P., Resnic, F. S., Piemonte, T. C., Barac, A., Patel, R., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.11.074 · Cited by 114 · cited 1×
“Although infrequent, it can lead to myocarditis in approximately 0.3% to 1.2% of cases, ranging from mild to severe clinical pictures, with the latter being associated with a substantial mortality rate ranging from 25% to 50% [17,18].”
BackgroundInfluentialCardiac sarcoidosis: diagnosis and management
Markatis, E., Afthinos, A., Antonakis, E., & Papanikolaou, I. C. (2020) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm.2020.03.102 · Cited by 111
Diagnostic Yield of Electroanatomic Voltage Mapping in Guiding Endomyocardial Biopsies
Casella, M., Russo, A. D., Bergonti, M., Catto, V., Conte, E., Sommariva, E., Gasperetti, A., Vettor, G., Tundo, F., Sicuso, R., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.046900 · Cited by 108 · cited 2×
“…acute HF or cardiogenic shock, such as in fulminant myocarditis cases, hemodynamic and mechanical circulatory support should be considered early [124]. systolic dysfunction occurs, guidelines-directed HF medical therapy is indicated, while in acute HF In myocarditis secondary to autoimmune or…”
BackgroundDiagnostic Accuracy of Advanced Imaging in Cardiac Sarcoidosis
Divakaran, S., Stewart, G. C., Lakdawala, N. K., Padera, R. F., Zhou, W., Desai, A. S., Givertz, M. M., Mehra, M. R., Kwong, R. Y. K., Hedgire, S., et al. (2019) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.118.008975 · Cited by 106 · cited 1×
“…and at least moderate fibrosis is a major criterion for diagnosis of sarcoidosis in the 2016 Japanese Cardiovascular Society on diagnosis and treatment of Cardiac Sarcoidosis [119], whereas the 2014 Heart Rhythm Society expert consensus considers as a histological criterion only the…”
BackgroundZhou, Y., Lower, E. E., Li, H., Costea, A., Attari, M., & Baughman, R. P. (2016) · CHEST Journal · doi:10.1016/j.chest.2016.08.1457 · Cited by 105
Myocarditis: A Clinical Overview
Caforio, A. L. P., Malipiero, G., Marcolongo, R., & Iliceto, S. (2017) · Current Cardiology Reports · doi:10.1007/s11886-017-0870-x · Cited by 105 · cited 2×
“…imaging techniques, and with tissue biopsy when needed, to recognize those that can be treated with targeted evidence-based therapeutic strategies [4]. to differentiate each of these different diseases more clearly, both clinically and with imaging techniques, and with tissue biopsy when needed,…”
BackgroundCardiac involvement in systemic sclerosis: Getting to the heart of the matter
Bruni, C., & Ross, L. (2021) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2021.101668 · Cited by 105 · cited 4×
“In older studies, SPECT could demonstrate rest-or stress-induced myocardial perfusion defects in the absence of coronary artery disease [65].”
BackgroundResultInfluentialNoutsias, M., Rohde, M., Göldner, K., Block, A., Blunert, K., Hemaidan, L., Hummel, M., Blohm, J.-H., Laßner, D., Kühl, U., et al. (2011) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfr014 · Cited by 104 · cited 1×
“Moreover, Th-17 lymphocytes and interleukin-17 have been implied in the progression to HF and ventricular dilation [22,23], while in enteroviral infections, some variants of Toll-Like Receptor 3 could blunt innate immune response to the pathogen, leading to a persistence of viral load and increased…”
BackgroundClinical characteristics and risk stratification of desmoplakin cardiomyopathy
Wang, W., Murray, B., Tichnell, C., Gilotra, N. A., Zimmerman, S. L., Gasperetti, A., Scheel, P., Tandri, H., Calkins, H., & James, C. A. (2022) · EP Europace · doi:10.1093/europace/euab183 · Cited by 103 · cited 1×
“In patients with acute HF without hemodynamic instability or arrhythmias and suspicion of inflammatory substrate, an EMB may be considered after CMR to define the type of inflammatory infiltrate before starting an immunosuppressive treatment [115,118].”
BackgroundThe spectrum of pericardial tamponade in systemic lupus erythematosus: Report of ten patients
Kahl, L. E. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780351115 · Cited by 101 · cited 1×
“Only 20% of patients with active SLE fulfilled clinical criteria for diagnosis of active myocarditis, while CMR was positive for myocarditis in 80% of patients [58].”
BackgroundBermúdez-Jiménez, F. J., Carriel, V., Brodehl, A., Alaminos, M., Campos, A., Schirmer, I., Milting, H., Abril, B. Á., Álvarez, M., López-Fernández, S., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.028719 · Cited by 101 · cited 1×
“A positive FDG-PET in a patient with persistent troponin elevation should trigger further diagnostic steps, such as an EMB, especially in the presence of arrhythmias [113].”
BackgroundMavrogeni, S. I., Bratis, K., Markussis, V., Spargias, C., Papadopoulou, E., Papamentzelopoulos, S., Constadoulakis, P., Matsoukas, E., Kyrou, L., & Kolovou, G. D. (2012) · Lupus · doi:10.1177/0961203312462265 · Cited by 100 · cited 1×
“The use of corticosteroids is often the fi rst line of treat-ment, frequently in combination with intravenous immunoglobulin, cyclophosphamide, or rituximab during the acute phase, while for maintenance therapy, mycophenolate mofetil”
BackgroundAmmirati, E., Buono, A., Moroni, F., Gigli, L., Power, J. R., Ciabatti, M., Garascia, A., Adler, E. D., & Pieroni, M. (2022) · Current Cardiology Reports · doi:10.1007/s11886-022-01680-x · Cited by 98 · cited 2×
“…in acute HF or cardiogenic shock, such as in fulminant myocarditis cases, hemodynamic and mechanical circulatory support should be considered early [124]. systolic dysfunction occurs, guidelines-directed HF medical therapy is indicated, while in acute HF In myocarditis secondary to autoimmune…”
BackgroundNakayama, T., Sugano, Y., Yokokawa, T., Nagai, T., Matsuyama, T.-A., Ohta-Ogo, K., Ikeda, Y., Ishibashi-Ueda, H., Nakatani, T., Ohte, N., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.767 · Cited by 97
Myopathic Cardiac Genotypes Increase Risk for Myocarditis
Kontorovich, A. R., Patel, N., Moscati, A., Richter, F., Peter, I., Purevjav, E., Selejan, S. R., Kindermann, I., Towbin, J. A., Bohm, M., et al. (2021) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2021.06.001 · Cited by 95 · cited 1×
“Genetic testing in this subset of myocarditis patients is an essential tool supporting the diagnosis of ARVC, and it should always be considered in case of a positive family history of cardiomyopathy or SCD [105].”
MethodFerri, C., Emdin, M., Giuggioli, D., Carpeggiani, C., Maielli, M., Varga, A., Michelassi, C., Pasero, G., & L'Abbate, A. (1997) · Rheumatology · doi:10.1093/rheumatology/36.6.669 · Cited by 93
HLA‐DQB1*0601 is primarily associated with the susceptibility to cardiac sarcoidosis
Naruse, T. K., Matsuzawa, Y., Ota, M., Katsuyama, Y., Matsumori, A., Hara, M., Nagai, S., Morimoto, S., Sasayama, S., & Inoko, H. (2000) · Tissue Antigens · doi:10.1034/j.1399-0039.2000.560107.x · Cited by 93 · cited 1×
“Furthermore, the use of LGE allows for the identification of necrosis or replacement fibrosis [34]; its persistence with the disappearance of edema is a marker of unfavorable prognosis, while the mid-wall septal LGE pattern is an independent predictor of cardiac events [35].”
Tan, J. L., Fong, H. K., Birati, E. Y., & Han, Y. (2019) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2018.10.021 · Cited by 89 · cited 1×
“Regardless of the primary myocardial involvement, as the disease progresses, patients develop HF symptoms and asymptomatic and symptomatic AVB.”
BackgroundShaikh, M., Jordan, N., & D’Cruz, D. P. (2017) · Clinical Medicine · doi:10.7861/clinmedicine.17-1-78 · Cited by 87 · cited 1×
“AVB and interventricular conduction abnormalities are less frequent compared to other systemic immune-mediated diseases, although they are more common in the pediatric population due to high serum levels of anti-Ro antibodies more pronounced in neonatal SLE [81].”
BackgroundProtonotarios, A., Wicks, E., Ashworth, M., Stephenson, E., Guttmann, O., Savvatis, K., Sekhri, N., Mohiddin, S. A., Syrris, P., Menezes, L., et al. (2019) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.10.083 · Cited by 85 · cited 2×
“…is a major criterion for diagnosis of sarcoidosis in the 2016 Japanese Cardiovascular Society on diagnosis and treatment of Cardiac Sarcoidosis [119], whereas the 2014 Heart Rhythm Society expert consensus considers as a histological criterion only the recognition of non-caseous granulomas [120].”
BackgroundResultPiriou, N., Marteau, L., Kyndt, F., Serfaty, J. M., Toquet, C. S., Gloan, L. L., Warin‐Fresse, K., Guijarro, D., Tourneau, T. L., Conan, E., et al. (2020) · ESC Heart Failure · doi:10.1002/ehf2.12686 · Cited by 75 · cited 1×
“However, although FDG-PET can be useful in the differential diagnosis of sarcoidosis due to extracar-diac uptake often seen in the latter, these two entities cannot always be distinguished using this method.”
MethodBrodehl, A., Belke, D. D., Garnett, L., Martens, K., Abdelfatah, N., Rodriguez, M., Diao, C., Chen, Y.-X., Gordon, P. M. K., Nygren, A., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0174019 · Cited by 71 · cited 1×
“A positive FDG-PET in a patient with persistent troponin elevation should trigger further diagnostic steps, such as an EMB, especially in the presence of arrhythmias [113].”
BackgroundEscher, F., Kasner, M., Kühl, U., Heymer, J., Wilkenshoff, U., Tschöpe, C., & Schultheiss, H.-P. (2013) · Mediators of Inflammation · doi:10.1155/2013/875420 · Cited by 70
Martins, D. S., Ovaert, C., Khraiche, D., Boddaert, N., Bonnet, D., & Raimondi, F. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.05.116 · Cited by 68 · cited 2×
“Desmoplakin (DSP) is the most common gene involved, accounting for 69% of cases, followed by plakophilin-2 (PKP-2), desmoglein-2 (DSG-2) desmin (DES), and the junction plakoglobin (JUP) gene, associated with Naxos disease; the mutation of other genes beyond desmosome has also been demonstrated to a…”
BackgroundMethodBariani, R., Rigato, I., Cipriani, A., Bueno Marinas, M., Celeghin, R., Basso, C., Corrado, D., Pilichou, K., & Bauce, B. (2022) · Biomolecules · doi:10.3390/biom12091324 · Cited by 67 · cited 1×
“Fatty replacement on CMR, seen as regions with chemical shift artifacts on cinematic sequences and elevated T2 values correlating with disease activity, may help identify such ARVC patients with acute inflammatory presentation [100].”
BackgroundHuman Herpesvirus-6: A Short Review of Its Biological Behavior
Krueger, G. R. F., & Ablashi, D. V. (2003) · Intervirology · doi:10.1159/000073205 · Cited by 62 · cited 2×
“Moreover, the first study to assess the efficacy of immunosuppression in AM demonstrated that prednisone combined with azathioprine or ciclosporin did not have a positive effect on LVEF or survival in patients with AM [126].”
BackgroundDefining primary systemic sclerosis heart involvement: A scoping literature review
Ross, L., Prior, D., Proudman, S., Vacca, A., Baron, M. G., & Nikpour, M. (2018) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2018.07.008 · Cited by 62 · cited 1×
“In a large registry study, patients with low LVEF were 5.5%, whereas global longitudinal strain and global circumferential strain proved to be effective in demonstrating deterioration of contractile function despite normal LVEF in patients with diastolic dysfunction [64].”
BackgroundInfluentialMacrophage diversity in cardiac inflammation: A review
Barin, J. G., Rose, N. R., & Čiháková, D. (2012) · Immunobiology · doi:10.1016/j.imbio.2011.06.009 · Cited by 56 · cited 1×
“Markers of cardiac damage, such as troponin and natriuretic peptides, might be only mildly elevated in the chronic quiescent setting or be significantly raised in acute decompensated phases [31].”
BackgroundGroh, M., Masciocco, G., Kirchner, E., Kristen, A. V., Pellegrini, C., Varnous, S., Bortman, G., Rosenberg, M., Brucato, A. L., Waterworth, P. D., et al. (2014) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2014.02.023 · Cited by 55 · cited 1×
“The use of corticosteroids is often the fi rst line of treat-ment, frequently in combination with intravenous immunoglobulin, cyclophosphamide, or rituximab during the acute phase, while for maintenance therapy, mycophenolate mofetil”
BackgroundZagelbaum, N. K., Linares-Koloffon, C. A., Posligua, A. L., Gandrabur, L., Kim, W. Y., Sperber, K. E., Wasserman, A. M., & Ash, J. Y. (2020) · Cardiology in Review · doi:10.1097/crd.0000000000000358 · Cited by 54
Interleukin-1 and Systemic Sclerosis: Getting to the Heart of Cardiac Involvement
Luca, G. D. D., Cavalli, G., Campochiaro, C., Bruni, C., Tomelleri, A., Dagna, L., & Matucci‐Cerinic, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.653950 · Cited by 54 · cited 1×
“Signs of autonomic dysfunction can be recognized using Holter ECG analysis in the form of a reduced heart rate variability and through exercise testing as an increase in heart rate time recovery [62].”
BackgroundKatz, G., Smilowitz, N. R., Blazer, A., Clancy, R. M., Buyon, J. P., & Berger, J. S. (2019) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2019.01.044 · Cited by 53 · cited 1×
“Only 20% of patients with active SLE fulfilled clinical criteria for diagnosis of active myocarditis, while CMR was positive for myocarditis in 80% of patients [58].”
BackgroundMarra, M. P., Rizzo, S., Bauce, B., Lazzari, M. D., Pilichou, K., Corrado, D., Thiene, G., Iliceto, S., & Basso, C. (2015) · Herz · doi:10.1007/s00059-015-4228-0 · Cited by 51
Early Detection of Cardiac Involvement in Systemic Sclerosis
Gargani, L., Todiere, G., Guiducci, S., Bruni, C., Pingitore, A., Marchi, D. D., Bellando-Randone, S., Aquaro, G. D., Bazzichi, L., Mosca, M., et al. (2018) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2018.09.025 · Cited by 48
Mutations in ILK, encoding integrin-linked kinase, are associated with arrhythmogenic cardiomyopathy
Brodehl, A., Rezazadeh, S., Williams, T., Munsie, N. M., Liedtke, D., Oh, T., Ferrier, R. A., Shen, Y., Jones, S. J. M., Stiegler, A. L., et al. (2019) · Translational research · doi:10.1016/j.trsl.2019.02.004 · Cited by 48 · cited 1×
“A positive FDG-PET in a patient with persistent troponin elevation should trigger further diagnostic steps, such as an EMB, especially in the presence of arrhythmias [113].”
BackgroundZampieri, M., Emmi, G., Beltrami, M., Fumagalli, C., Urban, M. L., Dei, L., Marchi, A. G., Berteotti, M., Tomberli, A., Baldini, K., et al. (2020) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2020.12.008 · Cited by 47 · cited 1×
“In patients with hypereosinophilia and/or EGPA who are asymptomatic from a cardiac perspective, identification of cardiac involvement is based on ECG and echocardiography, while advanced imaging should be reserved for selected patients or in case of acute symptomatic presentations.”
BackgroundSelf-citationAnti-heart autoantibodies in familial dilated cardiomyopathy
Caforio, A. L. P., Vinci, A., & Iliceto, S. (2008) · Autoimmunity · doi:10.1080/08916930802031546 · Cited by 43 · cited 1×
“CMR provides information on differential diagnosis (arrhythmogenic right ventricular cardiomyopathy, idiopathic DCM, sarcoidosis, hypertrophic of infiltrative cardiomyopathy, and ischemic or non-ischemic patterns).”
BackgroundBoogerd, C. J., Lacraz, G. P. A., Vértesy, Á., van Kampen, S. J., Perini, I., de Ruiter, H., Versteeg, D., Brodehl, A., van der Kraak, P., Giacca, M., et al. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvac072 · Cited by 43 · cited 1×
“Inflammatory infiltrates correlate with more severe structural cardiac abnormalities, implicating inflammatory triggers as a potential modulator of ARVC deterioration.”
BackgroundViral presence‐guided immunomodulation in lymphocytic myocarditis: an update
Sinagra, G., Porcari, A., Gentile, P., Artico, J., Fabris, E., Bussani, R., & Merlo, M. (2021) · European Journal of Heart Failure · doi:10.1002/ejhf.1969 · Cited by 42 · cited 1×
“Although the underlying mechanisms still remain unclear, both short-term and midterm prognoses have been reported to be favorable, thus prompting vaccination due to a clear benefit compared to associated risks [15].”
BackgroundPoindron, V., Chatelus, E., Canuet, M., Gottenberg, J., Arnaud, L., Gangi, A., Gavand, P., Guffroy, A., Korganow, A., Germain, P., et al. (2019) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2019.06.013 · Cited by 41
Brodehl, A., Weiß, J., Debus, J. D., Stanasiuk, C., Klauke, B., Deutsch, M. A., Fox, H., Bax, J., Ebbinghaus, H., Gärtner, A., et al. (2020) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2020.03.006 · Cited by 40 · cited 1×
“It has been suggested that genetically determined desmosomes malfunction predisposes cardiomyocytes to detachment and death and renders them more susceptible to injury by infectious pathogens [99].”
BackgroundMiszalski−Jamka, T., Szczeklik, W., Sokołowska, B. M., Karwat, K., Belzak, K., Mazur, W. M., Kereiakes, D. J., & Musiał, J. (2012) · International journal of cardiac imaging · doi:10.1007/s10554-012-0158-6 · Cited by 38 · cited 2×
“These cited studies and case reports showed an acute onset with severely depressed systolic function as the typical form of myocardial involvement in PS. Interestingly, a large real-world study on about 2 million patients demonstrated that PS is not an independent risk factor for DCM after…”
BackgroundREVERSIBLE MYOCARDIAL PERFUSION DEFECTS DURING COLD CHALLENGE IN SCLERODERMA
LONG, A., DUFFY, G., & Bresnihan, B. (1986) · Rheumatology · doi:10.1093/rheumatology/25.2.158 · Cited by 37
Electrocardiographic abnormalities and risk of developing cardiac events in extracardiac sarcoidosis
Nagao, S., Watanabe, H., Sobue, Y., Kodama, M., Tanaka, J., Tanabe, N., Suzuki, E., Narita, I., Watanabe, E., Aizawa, Y., et al. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.03.175 · Cited by 35 · cited 2×
“The EULAR Scleroderma Trials and Research (EUSTAR) database shows that cardiac causes account for 26% of SSc-related mortality.”
BackgroundEchocardiography in Sarcoidosis
Kurmann, R., Mankad, S. V., & Mankad, R. (2018) · Current Cardiology Reports · doi:10.1007/s11886-018-1065-9 · Cited by 34 · cited 1×
“In 90% of cases presenting as multiform PVCs, the most frequent cardiac manifestations are arrhythmias, while sustained ventricular tachycardia and supraventricular arrhythmias are less frequent.”
Backgroundvan Wijngaarden, S. E., Said-Bouyeri, S. B., Ninaber, M. K., Huizinga, T. W. J., Schalij, M. J., Bax, J. J., Delgado, V., Vries-Bouwstra, J. K. D., & Marsan, N. A. (2019) · The Journal of Rheumatology · doi:10.3899/jrheum.171207 · Cited by 33
Antiphospholipid Antibodies and Heart Valve Disease in Systemic Lupus Erythematosus
Ruiz, D., Oates, J. C., & Kamen, D. L. (2017) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2017.07.007 · Cited by 32 · cited 1×
“Only 20% of patients with active SLE fulfilled clinical criteria for diagnosis of active myocarditis, while CMR was positive for myocarditis in 80% of patients [58].”
BackgroundPsoriasis and Dilated Cardiomyopathy: Coincidence or Associated Diseases?
Eliakim‐Raz, N., Shuvy, M., Lotan, C., & Planer, D. (2008) · Cardiology · doi:10.1159/000121605 · Cited by 31 · cited 1×
“CMR showed high native T1 and T2 values associated with the hyperintensity of STIR T2 weighted images, demonstrating edema [90].”
BackgroundHussain, K., Gauto-Mariotti, E., Cattoni, H. M., Arif, A. W., Richardson, C., Manadan, A. M., & Yadav, N. (2020) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0000000000001464 · Cited by 30 · cited 1×
“Only 20% of patients with active SLE fulfilled clinical criteria for diagnosis of active myocarditis, while CMR was positive for myocarditis in 80% of patients [58].”
BackgroundNordin, A., Björnådal, L., Larsson, A. O., Svenungsson, E., & Jensen‐Urstad, K. (2014) · Scandinavian Journal of Rheumatology · doi:10.3109/03009742.2013.843720 · Cited by 29
Cardiac magnetic resonance in histologically proven eosinophilic myocarditis
Pöyhönen, P., Rågback, J., Mäyränpää, M. I., Nordenswan, H., Lehtonen, J. Y. A., Shenoy, C., & Kupari, M. M. (2023) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/s12968-023-00979-0 · Cited by 28 · cited 1×
“The most frequent clinical presentation, ECG, and imaging findings of systemic inflammatory diseases with cardiac involvement are shown in Table 1”
BackgroundŠramko, M., Kubánek, M., Tintěra, J., Kautznerová, D., Weichet, J., Malušková, J., Franeková, J., & Kautzner, J. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.09.024 · Cited by 25
Diagnosis of cardiac sarcoidosis: an era of paradigm shift
Sharma, A., Okada, D. R., Yacoub, H., Chrispin, J., & Bokhari, S. (2019) · Annals of Nuclear Medicine · doi:10.1007/s12149-019-01431-z · Cited by 23 · cited 1×
“Importantly, the presence of pulmonary hypertension, often secondary to lung involvement in SSc, must be carefully ruled out and followed up over time [58].”
BackgroundChoe, J., Lee, S., Kwak, S. G., & Kim, S. (2020) · Journal of Korean Medical Science · doi:10.3346/jkms.2020.35.e139 · Cited by 19 · cited 1×
“Only 20% of patients with active SLE fulfilled clinical criteria for diagnosis of active myocarditis, while CMR was positive for myocarditis in 80% of patients [58].”
BackgroundRossi, V. A., Gawinecka, J., Dimitriou, F., von Eckardstein, A., Dummer, R., Ruschitzka, F. T., & Matter, C. M. (2023) · ESC Heart Failure · doi:10.1002/ehf2.14360 · Cited by 19 · cited 1×
“Eosinophilic myocarditis is a relatively rare condition, and its presentation may vary from paucysintomatic AM to fulminant myocarditis; the inflammation may persist in subacute and chronic forms and evolve into restrictive cardiomyopathy (Loeffler syndrome).”
BackgroundSelf-citationFrustaci, A., Galea, N., Dominici, L., Verardo, R., Alfarano, M., Scialla, R., & Richetta, A. G. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12124010 · Cited by 18 · cited 3×
“Close collaboration between cardiologists and other specialists should be promoted to identify cardiac involvement promptly and define therapeutic strategies and prognostication.”
BackgroundFilippetti, L., Mandry, D., Venner, C., Juillière, Y., Sadoul, N., Girerd, N., Lamiral, Z., Selton‐Suty, C., Marie, P., & Huttin, O. (2018) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2018.02.008 · Cited by 16
Battisha, A., Sawalha, K., Altibi, A. M. A., Madoukh, B., Al‐Akchar, M., & Patel, B. D. (2020) · Heart Failure Reviews · doi:10.1007/s10741-020-09990-4 · Cited by 15
Kobayashi, Y., Nagai, T., Takenaka, S., Kato, Y., Komoriyama, H., Nagano, N., Kamiya, K., Konishi, T., Sato, T., Omote, K., et al. (2021) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2021.04.039 · Cited by 14
Ammirati, E., Lupi, L., Palazzini, M., Ciabatti, M., Rossi, V. A., Gentile, P., Uribarri, A., Vecchio, C., Nassiacos, D., Cereda, A. F., et al. (2023) · Circulation Heart Failure · doi:10.1161/circheartfailure.122.010315 · Cited by 10 · cited 1×
“GCM is a rare disorder presenting often with a fulminant course requiring a prompt histological diagnosis and immediate immunosuppressive treatment [16].”
BackgroundSelf-citationAlshami, A., Alfraji, N., Douedi, S., Patel, S., Hossain, M., Alpert, D. R., & Calderon, D. (2021) · BMC Cardiovascular Disorders · doi:10.1186/s12872-021-01972-0 · Cited by 6 · cited 1×
“CMR showed high native T1 and T2 values associated with the hyperintensity of STIR T2 weighted images, demonstrating edema [90].”
BackgroundFrustaci, A., Galea, N., Dominici, L., et al. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4325223 · Cited by 5
Li, W., Ge, L., & Li, Y. (2023) · Echocardiography · doi:10.1111/echo.15562 · Cited by 4
Liu, Y., Hsu, J., Liu, X., Lin, X., Zhu, Y., Jia, F., Wu, W., Chen, W., Wang, Q., & Fang, L. (2022) · Annals of Noninvasive Electrocardiology · doi:10.1111/anec.12938 · Cited by 3
Guan, F., Wolber, T., Saguner, A. M., Medeiros, A., Müggler, O., Berger, F., Gass, M., Molitor, N., Ruschitzka, F. T., Brunckhorst, C., et al. (2023) · HeartRhythm Case Reports · doi:10.1016/j.hrcr.2023.03.017 · Cited by 3 · cited 1×
“This pattern is peculiar for DSP cardiomyopathy, although it has also been observed in gene-elusive cases, in which the extent of LGE has a strong correlation with arrhythmic adverse events [112].”
Shigeyama (2000) · doi:10.1002/1529-0131(200011)43:11
Cited by
Netala, V. R., Teertam, S. K., Li, H., & Zhang, Z. (2024) · Cells · doi:10.3390/cells13171471 · Cited by 236
Przytuła, N., Podolec, J., Przewłocki, T., Podolec, P. S., & Kabłak-Ziembicka, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262211003 · Cited by 14
Inflammatory cardiomyopathy: an update for clinicians
Imazio, M. (2025) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2025.07.003 · Cited by 9
Zhuang, Y., Yan, Y., Zheng, W., Rao, X., Jiang, J., Li, H., & Wang, D. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103970 · Cited by 8
“…in intensive care and immunomodulatory therapies have reduced acute mortality from myocarditis, a substantial proportion of survivors progress to chronic inflammatory cardiomyopathy characterized by persistent low-grade inflammation, ventricular dilation, and fibrotic remodeling [11,25,26].”
Infarct-like myocarditis in adolescents: Exploring genetic insights from diagnosis through follow-up
Esmel-Vilomara, R., Riaza, L., Dolader, P., Rodríguez‐Santiago, B., Lasa‐Aranzasti, A., Muñoz‐Cabello, P., Fernández‐Álvarez, P., Figueras-Coll, M., Bianco, L., Bueno-Gómez, A., et al. (2025) · International Journal of Cardiology · doi:10.1016/j.ijcard.2025.133255 · Cited by 7
Metadata
- Authors
- Uccello, G., Bonacchi, G., Rossi, V. A., Montrasio, G., & Beltrami, M.
- Affiliations
- Alessandro Manzoni Hospital (IT)
- Policlinico Tor Vergata (IT)
- University Hospital Zurich (CH)
- St Bartholomew's Hospital (GB)
- Azienda Ospedaliero-Universitaria Careggi (IT)
- Corresponding author
- Beltrami, Matteo
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2023-12-27
- Volume
- 13
- Issue
- 1
- Pages
- 150
- ISSN
- 2077-0383 (ISSN-L)
- PMC
- PMC10780032
- OpenAlex
- W4390273166
- Cited by
- 33
- References
- 133
- Citations by year
- 2026: 11 · 2025: 18 · 2024: 4
- FWCI
- 1.74
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by)
- Use Siena air (University of Siena) (submittedVersion, cc-by)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by)
- Zurich Open Repository and Archive (University of Zurich)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Keywords
- acute myocarditis, dilated cardiomyopathy, heart failure, ventricular arrhythmias, hemodynamic instability, cardiac magnetic resonance, endomyocardial biopsy, genotype-phenotype correlation, genetic counseling, pathophysiology, disease progression, early diagnosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.